Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Haemonetics (NYSE:HAE) through any online brokerage.
Other companies in Haemonetics’s space includes: Medline Inc (NASDAQ:MDLN), Alcon Inc (NYSE:ALC), Solventum Corp (NYSE:SOLV), The Cooper Companies Inc (NASDAQ:COO) and Align Technology Inc (NASDAQ:ALGN).
Haemonetics has a consensus price target of $112.09.
The stock price for Haemonetics (NYSE: HAE) is $122.54 last updated October 13, 2026 at 12:26 PM EDT.
There are no upcoming dividends for Haemonetics.
Haemonetics does not have any upcoming earnings scheduled.
There is no upcoming split for Haemonetics.
Haemonetics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.